Hinge Health, Inc. (HNGE) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $38.78. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HNGE = $85.45 (+120.3% from the current price, the stock appears undervalued). Analyst consensus target is HNGE = $57 (+46.7% upside).
Valuation: HNGE trades at a trailing Price-to-Earnings (P/E) of -5.6 (S&P 500 average ~25).
Financials: revenue is $588M, +42%/yr average growth. Net income is $528M (loss), growing at -2119%/yr. Net profit margin is -89.9% (negative). Gross margin is 79.6% (+13.3 pp trend).
Balance sheet: total debt is $8M against $379M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 1.47 (adequate). Debt-to-assets is 1.1%. Total assets: $745M.
Analyst outlook: 12 / 12 analysts rate HNGE as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 75/100 (Pass), Moat 70/100 (Pass), Future 100/100 (Pass), Income 10/100 (Fail).
